Dose-dependent multi-organ injury following lipopolysaccharide gas inhalation.
J Int Med Res
; 52(5): 3000605241247707, 2024 May.
Article
en En
| MEDLINE
| ID: mdl-38717029
ABSTRACT
Lipopolysaccharide (LPS) is widely used to establish various animal models, including models of acute lung injury, cardiomyocyte damage, and acute kidney injury. Currently, there is no consensus on the diagnosis and treatment of LPS-induced disease. We herein present a case series of four patients who developed dose-dependent multi-organ injury, including acute lung injury and acute kidney injury, after inhaling LPS gas in a sealed room. These patients exhibited varying degrees of multi-organ injury characterized by inflammatory cell infiltration and secretion of proinflammatory cytokines. One patient showed progressive symptoms even with active treatment, leading to mild pulmonary fibrosis. This study emphasizes the importance of early diagnosis and treatment of significant LPS exposure and suggests personalized treatment approaches for managing LPS poisoning.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Lipopolisacáridos
Idioma:
En
Revista:
J Int Med Res
Año:
2024
Tipo del documento:
Article